Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
1993 1
1995 3
1996 4
1997 2
1998 1
1999 1
2001 2
2002 3
2003 1
2004 1
2005 1
2006 1
2008 4
2009 3
2010 3
2011 5
2012 1
2013 1
2014 3
2015 3
2016 4
2017 8
2018 9
2019 6
2020 10
2021 6
2022 5
2023 5
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

89 results

Results by year

Filters applied: . Clear all
Page 1
Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes.
Kirchhof P, Toennis T, Goette A, Camm AJ, Diener HC, Becher N, Bertaglia E, Blomstrom Lundqvist C, Borlich M, Brandes A, Cabanelas N, Calvert M, Chlouverakis G, Dan GA, de Groot JR, Dichtl W, Kravchuk B, Lubiński A, Marijon E, Merkely B, Mont L, Ozga AK, Rajappan K, Sarkozy A, Scherr D, Sznajder R, Velchev V, Wichterle D, Sehner S, Simantirakis E, Lip GYH, Vardas P, Schotten U, Zapf A; NOAH-AFNET 6 Investigators; NOAH-AFNET6 sites and investigators. Kirchhof P, et al. N Engl J Med. 2023 Sep 28;389(13):1167-1179. doi: 10.1056/NEJMoa2303062. Epub 2023 Aug 25. N Engl J Med. 2023. PMID: 37622677 Clinical Trial.
Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia.
Arenal Á, Ávila P, Jiménez-Candil J, Tercedor L, Calvo D, Arribas F, Fernández-Portales J, Merino JL, Hernández-Madrid A, Fernández-Avilés FJ, Berruezo A. Arenal Á, et al. Among authors: tercedor l. J Am Coll Cardiol. 2022 Apr 19;79(15):1441-1453. doi: 10.1016/j.jacc.2022.01.050. J Am Coll Cardiol. 2022. PMID: 35422240 Free article. Clinical Trial.
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR.
Van Mieghem NM, Unverdorben M, Hengstenberg C, Möllmann H, Mehran R, López-Otero D, Nombela-Franco L, Moreno R, Nordbeck P, Thiele H, Lang I, Zamorano JL, Shawl F, Yamamoto M, Watanabe Y, Hayashida K, Hambrecht R, Meincke F, Vranckx P, Jin J, Boersma E, Rodés-Cabau J, Ohlmann P, Capranzano P, Kim HS, Pilgrim T, Anderson R, Baber U, Duggal A, Laeis P, Lanz H, Chen C, Valgimigli M, Veltkamp R, Saito S, Dangas GD; ENVISAGE-TAVI AF Investigators. Van Mieghem NM, et al. N Engl J Med. 2021 Dec 2;385(23):2150-2160. doi: 10.1056/NEJMoa2111016. Epub 2021 Aug 28. N Engl J Med. 2021. PMID: 34449183 Clinical Trial.
Comments on the 2019 ESC guidelines on supraventricular tachycardia.
SEC Working Group for the 2019 ESC guidelines on supraventricular tachycardia, Expert Reviewers for the 2019 ESC guidelines on supraventricular tachycardia, SEC Guidelines Committee; SEC Working Group for the 2019 ESC guidelines on supraventricular tachycardia; Expert Reviewers for the 2019 ESC guidelines on supraventricular tachycardia; SEC Guidelines Committee. SEC Working Group for the 2019 ESC guidelines on supraventricular tachycardia, Expert Reviewers for the 2019 ESC guidelines on supraventricular tachycardia, SEC Guidelines Committee, et al. Rev Esp Cardiol (Engl Ed). 2020 Jun;73(6):445-451. doi: 10.1016/j.rec.2019.12.024. Epub 2020 Apr 26. Rev Esp Cardiol (Engl Ed). 2020. PMID: 32349912 English, Spanish. No abstract available.
Proteomics and Recurrence of Atrial Fibrillation: A Pilot Study Nested in the PREDIMAR Trial.
Razquin C, Fernandez-Irigoyen J, Barrio-López MT, López B, Ravassa S, Ramos P, Macías-Ruíz R, Ibañez Criado A, Santamaría E, Goni L, Castellanos E, Ibañez Criado JL, Tercedor L, García-Bolao I, Martínez-González MA, Almendral J, Ruiz-Canela M. Razquin C, et al. Among authors: tercedor l. Lifestyle Genom. 2025;18(1):52-58. doi: 10.1159/000543639. Epub 2025 Jan 24. Lifestyle Genom. 2025. PMID: 39864423 Free article.
Cardiac Manifestations of Neuromuscular Disease.
Rodríguez-Torres D, Jiménez-Jáimez J, Macías-Ruiz R, Álvarez-López M, Tercedor L. Rodríguez-Torres D, et al. Among authors: tercedor l. Rev Esp Cardiol (Engl Ed). 2018 Jul;71(7):580-582. doi: 10.1016/j.rec.2017.03.033. Epub 2017 Jun 7. Rev Esp Cardiol (Engl Ed). 2018. PMID: 28601412 English, Spanish. No abstract available.
Myocardial fibrosis in arrhythmogenic cardiomyopathy: a genotype-phenotype correlation study.
Segura-Rodríguez D, Bermúdez-Jiménez FJ, Carriel V, López-Fernández S, González-Molina M, Oyonarte Ramírez JM, Fernández-Navarro L, García-Roa MD, Cabrerizo EM, Durand-Herrera D, Alaminos M, Campos A, Macías R, Álvarez M, Tercedor L, Jiménez-Jáimez J. Segura-Rodríguez D, et al. Among authors: tercedor l. Eur Heart J Cardiovasc Imaging. 2020 Apr 1;21(4):378-386. doi: 10.1093/ehjci/jez277. Eur Heart J Cardiovasc Imaging. 2020. PMID: 31702781 Free article.
89 results